SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 274 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $993,000 | -29.3% | 41,827 | -18.2% | 0.13% | -68.6% |
| Q3 2019 | $1,405,000 | -17.1% | 51,143 | -0.1% | 0.40% | -17.7% |
| Q2 2019 | $1,694,000 | -5.5% | 51,183 | +0.0% | 0.49% | -9.7% |
| Q1 2019 | $1,793,000 | +123.3% | 51,171 | +111.6% | 0.54% | +92.6% |
| Q4 2018 | $803,000 | -23.2% | 24,182 | +16.5% | 0.28% | -55.7% |
| Q3 2018 | $1,045,000 | -15.8% | 20,750 | 0.0% | 0.64% | +48.6% |
| Q2 2018 | $1,241,000 | +80.6% | 20,750 | +38.3% | 0.43% | +73.4% |
| Q1 2018 | $687,000 | +14.9% | 15,000 | 0.0% | 0.25% | +15.3% |
| Q4 2017 | $598,000 | – | 15,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |